Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
An update from China’s NMPA clarifying registration requirements and classification methods for drug-device combination products has been welcomed by industry as the regulator seeks to keep pace with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback